Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on BH011 evaluating safety, tolerability, and preliminary efficacy in non-muscle-invasive bladder cancer across Phase 1 and Phase 2, cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• BH011

Snippet

Sponsor: Zhuhai Beihai Biotech Co., Ltd | Conditions: Bladder Cancer, Non Muscle Invasive | Phase 1, Phase 2 | Status: RECRUITING